{"name":"Dipan Shah","slug":"dipan-shah","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-12-15","type":"regulatory","source":"The Economic Times","summary":"Amish Shah turns bullish on pharma, remains cautious on IT - The Economic Times","headline":"Amish Shah turns bullish on pharma, remains cautious on IT","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-09","type":"pipeline","source":"The Economic Times","summary":"Pharma set for upside on tariff clarity; Lupin, RBL Bank among top picks: Rahul Shah - The Economic Times","headline":"Pharma set for upside on tariff clarity; Lupin, RBL Bank among top picks: Rahul Shah","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-12-17","type":"pipeline","source":"The Economic Times","summary":"Banking & IT could account for 60% of Gautam Shah's Portfolio 2025. Here’s why - The Economic Times","headline":"Banking & IT could account for 60% of Gautam Shah's Portfolio 2025. Here’s why","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-10-23","type":"pipeline","source":"The Economic Times","summary":"Not only IT or pharma, next one year, go for gold and silver: Gautam Shah - The Economic Times","headline":"Not only IT or pharma, next one year, go for gold and silver: Gautam Shah","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}